Evidence map›Paper›PMID 36112587›Full record

ArticlePloS one2022

Single- and duplex TaqMan-quantitative PCR for determining the copy numbers of integrated selection markers during site-specific mutagenesis in Toxoplasma gondii by CRISPR-Cas9.

Kai Pascal Alexander Hänggeli, Andrew Hemphill, Norbert Müller, Bernd Schimanski, Philipp Olias, Joachim Müller, Ghalia Boubaker

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. TaqMan-quantitative PCR assays applied inFrontiers in cellular and infection microbiology · 2024
    Article
  5. Comparative Proteomic Analysis ofInternational journal of molecular sciences · 2023
    Article
  6. High prevalence rates ofInternational journal for parasitology. Parasites and wildlife · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Kai Pascal Alexander HänggeliDepartment of Infectious Diseases and Pathobiology, Institute of Parasitology, University of Bern, Bern, Switzerland.
Andrew HemphillDepartment of Infectious Diseases and Pathobiology, Institute of Parasitology, University of Bern, Bern, Switzerland.ORCID 0000-0002-0622-2128
Norbert MüllerDepartment of Infectious Diseases and Pathobiology, Institute of Parasitology, University of Bern, Bern, Switzerland.
Bernd SchimanskiDepartment of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Bern, Switzerland.ORCID 0000-0003-1336-3671
Philipp OliasInstitute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
Joachim MüllerDepartment of Infectious Diseases and Pathobiology, Institute of Parasitology, University of Bern, Bern, Switzerland.
Ghalia BoubakerDepartment of Infectious Diseases and Pathobiology, Institute of Parasitology, University of Bern, Bern, Switzerland.
University of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Herein, we developed a single and a duplex TaqMan quantitative PCR (qPCR) for absolute quantification of copy numbers of integrated dihydrofolate reductase-thymidylate synthase (mdhfr-ts) drug selectable marker for pyrimethamine resistance in Toxoplasma gondii knockouts (KOs). The single TaqMan qPCR amplifies a 174 bp DNA fragment of the inserted mdhfr-ts and of the wild-type (WT) dhfr-ts (wtdhfr-ts) which is present as single copy gene in Toxoplasma and encodes a sensitive enzyme to pyrimethamine. Thus, the copy number of the dhfr-ts fragment in a given DNA quantity from KO parasites with a single site-specific integration should be twice the number of dhfr-ts copies recorded in the same DNA quantity from WT parasites. The duplex TaqMan qPCR allows simultaneous amplification of the 174 bp dhfr-ts fragment and the T. gondii 529-bp repeat element. Accordingly, for a WT DNA sample, the determined number of tachyzoites given by dhfr-ts amplification is equal to the number of tachyzoites determined by amplification of the Toxoplasma 529-bp, resulting thus in a ratio of 1. However, for a KO clone having a single site-specific integration of mdhfr-ts, the calculated ratio is 2. We then applied both approaches to test T. gondii RH mutants in which the major surface antigen (SAG1) was disrupted through insertion of mdhfr-ts using CRISPR-Cas9. Results from both assays were in correlation showing a high accuracy in detecting KOs with multiple integrated mdhfr-ts. Southern blot analyses using BsaBI and DraIII confirmed qPCRs results. Both TaqMan qPCRs are needed for reliable diagnostic of T. gondii KOs following CRISPR-Cas9-mediated mutagenesis, particularly with respect to off-target effects resulting from multiple insertions of mdhfr-ts. The principle of the duplex TaqMan qPCR is applicable for other selectable markers in Toxoplasma. TaqMan qPCR tools may contribute to more frequent use of WT Toxoplasma strains during functional genomics.

Indexed as

Thymidylate SynthaseToxoplasmaAntigens, SurfaceCRISPR-Cas SystemsDNADNA Copy Number VariationsMutagenesis, Site-DirectedPolymerase Chain ReactionPyrimethamineTetrahydrofolate DehydrogenaseAntigens, SurfaceDNAPyrimethamineTetrahydrofolate DehydrogenaseThymidylate Synthase

Identifiers

PMID36112587
PMCPMC9481009
OpenAlexW4296026574

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.